Interferonγ and tumour necrosis factorα induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro
- 1 October 1993
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 119 (10) , 615-621
- https://doi.org/10.1007/bf01372725
Abstract
Three human cell lines derived from Ewing's sarcoma (RM-82, VH-64, and WE-68) were investigated to establish the influence of recombinant human interferon γ (rhIFNγ) and tumour necrosis factor α (rhTNFα) on cell proliferation and survival and to characterize IFNγ and TNFα receptor expression. Incorporation of [3H]thymidine into cells was inhibited by rhIFNγ after 24 h of incubation. Half-maximal inhibition was observed with 10–80 U/ml rhIFNγ. A maximal effect (50%–70% inhibition of cell proliferation) was achieved by treatment of cells with 250 U/ml rhIFNγ. The influence of rhTNFα on proliferation was found to differ among cell lines and varied with the concentration and the duration of exposure of cells to this cytokine. In WE-68 and VH-64 cells [3H]thymidine incorporation was not affected by rhTNFα up to 2000 U/ml after 96 h of incubation, where-as in RM-82 cells the incorporation was inhibited by 35% after 48 h of incubation with 100 U/ml rhTNFα. However, all cell lines showed a synergistic antiproliferative response to the combination of rhIFNγ and rhTNFα after 24 h of incubation. The human recombinant cytokines interleukin(IL)-1α, IL-1β, IL-2, IL-3, IL-4, IL-6 and granulocyte/macrophagecolony-stimulating factor, tested alone and in combination with rhIFNγ and rhTNFα, had no influence on cell proliferation. Binding studies in the cell lines with125I-rhIFNγ revealed a dissociation constant (K d ) of 160–306 pM and approximately 8000–13500 receptors/cell. Binding experiments with125I-rhTNFα indicated 430–1250 receptors/cell withK d ranging from 13 pM to 162 pM. These data indicate that, among various cytokines, only IFN and TNFα are capable of potently reducing Ewing's sarcoma cell growth in vitro. Our data suggest that IFN alone or in combination with TNFα may be useful in the design of novel strategies in Ewing's sarcoma therapy.Keywords
This publication has 43 references indexed in Scilit:
- Expression of functional Y1 receptors for neuropeptide Y in human Ewing's sarcoma cell linesZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- Type I and type II insulin-like growth factor receptors and their function in human Ewing's sarcoma cellsZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- Inhibition of the growth of cultured human meningioma cells by recombinant interferon-αEuropean Journal of Cancer and Clinical Oncology, 1991
- Isolation of Human Colon Carcinoma Cells for Resistance to a Single Interferon Associated With Cross-Resistance to Multiple Recombinant Interferons: , beta, andJNCI Journal of the National Cancer Institute, 1990
- Specific binding of interferon-.GAMMA. and -.ALPHA.2a to tumor cells and their antitumo activities.Journal of Pharmacobio-Dynamics, 1988
- Recombinant tumor necrosis factor: its effect and its synergism with interferon-γ on a variety of normal and transformed human cell linesEuropean Journal of Cancer and Clinical Oncology, 1986
- Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.The Journal of Experimental Medicine, 1986
- High affinity binding of 125I-labeled human tumor necrosis factor (LuKII) to specific cell surface receptors.The Journal of Experimental Medicine, 1985
- Immune interferon: a pleiotropic lymphokine with multiple effectsImmunology Today, 1985
- Interferon receptor interaction. Internalization of interferon alpha2 and modulation of its receptor on human cellsEuropean Journal of Biochemistry, 1984